Evidence map›Paper›PMID 42286065›Full record

ArticleScientific reports2026

Optimization of ciprofloxacin removal from aqueous solutions using the TiO

Mansour Ghaderpoori, Maryam Yaghobi, Faramarz Azimi, Bahram Kamarehie, Ali Toolabi

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mansour GhaderpooriEnvironmental Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.
Maryam YaghobiStudent Research Committee, Lorestan University of Medical Sciences, Khorramabad, Iran.
Faramarz AzimiEnvironmental Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.
Bahram KamarehieEnvironmental Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran.
Ali ToolabiEnvironmental Health Research Center, Lorestan University of Medical Sciences, Khorramabad, Iran. atoolabi@yahoo.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ciprofloxacin (CIP) is a widespread environmental pollutant due to its high chemical stability and frequent presence in aquatic environments. Even at low concentrations, it poses serious risks to human health and ecosystems. This study aimed to optimize the photocatalytic degradation of CIP and evaluate the toxicity of the treated effluent from aqueous solutions. The experiments were conducted in batch mode using a 3 L photocatalytic reactor. Experimental optimization was performed using the Central Composite Design (CCD), considering pH, contact time, CIP concentration, and nanoparticle dose as variables. TiO

Indexed as

CiprofloxacinTitaniumWater Pollutants, ChemicalWater PurificationXanthenesAnti-Bacterial AgentsEscherichia coliNanocompositesOxazinesSpectroscopy, Fourier Transform InfraredUltraviolet RaysX-Ray DiffractionAnti-Bacterial AgentsCiprofloxacinOxazinesresazurinTitaniumtitanium dioxideWater Pollutants, ChemicalXanthenesCiprofloxacinE. coliOptimizationPhotocatalytic processesResazurin

Identifiers

PMID42286065
PMCPMC13507174

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.